2012
DOI: 10.1007/s10552-012-0011-1
|View full text |Cite
|
Sign up to set email alerts
|

Liquid-based cervical cytology using ThinPrep technology: weighing the pros and cons in a cost-effectiveness analysis

Abstract: Regarding test characteristics and costs of LBC and CP, only under certain conditions will a change from CP to manually screened ThinPrep LBC be cost-effective. If none of these conditions are met, implementation of manually screened ThinPrep LBC seems warranted only if there are advantages other than cost-effectiveness. Further research is needed to establish whether other LBC systems will be more favorable with regard to cost-effectiveness.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
19
0
2

Year Published

2014
2014
2024
2024

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 26 publications
(21 citation statements)
references
References 31 publications
0
19
0
2
Order By: Relevance
“…A study by Taylor et al 20 found that a commonly used LBC product reduced the number of inadequate smears but did not improve detection of histology-confirmed disease (cervical intraepithelial neoplasia grade 1 or worse) and therefore concluded that the increased cost does not justify the implementation of LBC. In contrast, a review by Cox 21 showed that LBC was cost-effective. A study by de Bekker-Grob et al 22 similarly determined that LBC can be cost-effective as a cervical screening modality, specifically if the cost of LBC exceeded the cost of conventional cytology by less than €3.2, the sensitivity of LBC was at least 3% – 5% greater than conventional cytology and the rate of inadequate smears on conventional cytology was at least 16.2%.…”
Section: Discussionmentioning
confidence: 93%
“…A study by Taylor et al 20 found that a commonly used LBC product reduced the number of inadequate smears but did not improve detection of histology-confirmed disease (cervical intraepithelial neoplasia grade 1 or worse) and therefore concluded that the increased cost does not justify the implementation of LBC. In contrast, a review by Cox 21 showed that LBC was cost-effective. A study by de Bekker-Grob et al 22 similarly determined that LBC can be cost-effective as a cervical screening modality, specifically if the cost of LBC exceeded the cost of conventional cytology by less than €3.2, the sensitivity of LBC was at least 3% – 5% greater than conventional cytology and the rate of inadequate smears on conventional cytology was at least 16.2%.…”
Section: Discussionmentioning
confidence: 93%
“…The findings from our study are consistent with those reported in an Australian 31 and UK study. 32 However, they contradict the findings from studies conducted in The Netherlands 33 and France. 34 NICE approved LBC for use within the UK's National Health Service (NHS).…”
Section: Discussionmentioning
confidence: 85%
“…In 2004, Ferraz et al compared the results of pap smear test with liquid-based cytology over 800 women. They reported the sensitivity and specificity of liquid based system for detection of cervical intraepithelial lesions and cancer were 75.3% and 86.4%, respectively, not statistically different from the 81.8% and 85.2% seen with the conventional method (19).…”
Section: Discussionmentioning
confidence: 92%